3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
21
Prostatic Neoplasms
11
Neoplasms
8
Head and Neck Neoplasms
8
Ovarian Neoplasms
6
Oropharyngeal Neoplasms
4
Lung Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Sarcoma
3
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Pancreatic Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma, Renal Cell
3
Brain Neoplasms
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Psychological Well-Being
2
Motor Activity
2
Melanoma
2
Kidney Neoplasms
2
Hematologic Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Communication
2
Colonic Neoplasms
2
Central Nervous System Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
relugolix
2
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
2
Specimen Handling
2
Radiotherapy
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Leuprolide
2
Goserelin
2
Biopsy
2
radium Ra 223 dichloride
1
luprolide acetate gel depot
1
histrelin
1
gallium 68 PSMA-11
1
enzalutamide
1
darolutamide
1
bicalutamide
1
Triptorelin Pamoate
1
Surgical Procedures, Operative
1
Salicylic Acid
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Flutamide
1
Buserelin
1
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostate Adenocarcinoma
×
Surveys and Questionnaires
×
90 days
×
Clear all
No trials found.